Grifols

Grifols is a global healthcare company founded in Barcelona, Spain, in 1909. With over 23,800 employees across more than 30 countries, Grifols is dedicated to improving the health and well-being of people worldwide.

Specializing in the development, production, and marketing of plasma-derived medicines, Grifols addresses chronic, rare, and life-threatening conditions.

Their product portfolio includes immunoglobulins for immunodeficiencies, albumin for circulatory volume restoration, alpha-1 proteinase inhibitors for genetic emphysema, and clotting factors for hemophilia.

In addition to biopharmaceuticals, Grifols is a leader in transfusion medicine, offering diagnostic solutions that enhance disease detection and management.

The company also provides biological materials for life-science research and supplies tools and services to hospitals and pharmacies for efficient medical care delivery.

Global Plasma Donation Centers

Grifols operates the world's largest network of plasma donation centers, with approximately 400 centers across:

• North America
• Europe
• Africa
• The Middle East
• China

This extensive network ensures a reliable source of plasma for their medicines.

Presence in the United States

In the U.S., Grifols has a significant presence with manufacturing and operational sites:

• Clayton, North Carolina
• Los Angeles, California
• Emeryville, California
• Denver, Colorado
• San Diego, California
• Vista, California
• San Marcos, Texas
• Austin, Texas
• Memphis, Tennessee
• Boca Raton, Florida
• Glendale, Arizona
• Bensalem, Pennsylvania
• Lawton, Oklahoma

The company employs over 13,000 people in the U.S., serving patients and healthcare professionals nationwide.

Commitment to Innovation

Grifols' dedication to innovation and quality is evident in its continuous research and development efforts.

The goal is to provide life-saving therapies and diagnostic solutions to patients globally.